Hepatology (Baltimore, Md.)
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
New drugs for non-alcoholic steatohepatitis and HIV infection: great expectations with a great absent?
Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis.
National Experience on Down-staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP, and Wait Time.
Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults.
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
Reply (to LTE HEP-19-0464).
The Spectrum of Hepatic Involvement in Patients with Telomere Disease.
Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol.
